Aperio Group’s Fate Therapeutics FATE Stock Holding History

Aperio Group’s Portfolio FATE Stock Details FATE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$1.25M	Buy
2020 Q3	$400K	Buy
2020 Q2	$275K	Buy
2019 Q3	–	Sell
2019 Q2	$79K	Buy